98 related articles for article (PubMed ID: 25300021)
1. Photocatalytic degradation of rosuvastatin: analytical studies and toxicity evaluations.
Machado TC; Pizzolato TM; Arenzon A; Segalin J; Lansarin MA
Sci Total Environ; 2015 Jan; 502():571-7. PubMed ID: 25300021
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug development.
Shah RP; Sahu A; Singh S
Anal Bioanal Chem; 2013 Apr; 405(10):3215-31. PubMed ID: 23386001
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin calcium.
Quirk J; Thornton M; Kirkpatrick P
Nat Rev Drug Discov; 2003 Oct; 2(10):769-70. PubMed ID: 14579811
[No Abstract] [Full Text] [Related]
4. Degradation mechanism and the toxicity assessment in TiO2 photocatalysis and photolysis of parathion.
Kim TS; Kim JK; Choi K; Stenstrom MK; Zoh KD
Chemosphere; 2006 Feb; 62(6):926-33. PubMed ID: 16051312
[TBL] [Abstract][Full Text] [Related]
5. UV and solar photo-degradation of naproxen: TiO₂ catalyst effect, reaction kinetics, products identification and toxicity assessment.
Jallouli N; Elghniji K; Hentati O; Ribeiro AR; Silva AM; Ksibi M
J Hazard Mater; 2016 Mar; 304():329-36. PubMed ID: 26571001
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro release of microparticles based on dextran-rosuvastatin conjugate.
Zhou C; Gao W; Lu G; Ding J; Wu X; Huang X; Chen J; Liu M; Jiang J; Wu H
Carbohydr Polym; 2013 Jul; 96(1):156-62. PubMed ID: 23688465
[TBL] [Abstract][Full Text] [Related]
7. Determination of rosuvastatin in urine by spectrofluorimetry after liquid-liquid extraction and derivatization in acidic medium.
Braga VS; Mancilha TP; Cassella RJ; Pacheco WF
J Fluoresc; 2013 Jan; 23(1):49-55. PubMed ID: 22903763
[TBL] [Abstract][Full Text] [Related]
8. Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals.
Rizzo L; Meric S; Guida M; Kassinos D; Belgiorno V
Water Res; 2009 Sep; 43(16):4070-8. PubMed ID: 19596131
[TBL] [Abstract][Full Text] [Related]
9. Effect of medium pH on the cytotoxicity of hydrophilic statins.
Kobayashi M; Kagawa T; Takano R; Itagaki S; Hirano T; Iseki K
J Pharm Pharm Sci; 2007; 10(3):332-9. PubMed ID: 17727796
[TBL] [Abstract][Full Text] [Related]
10. Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct.
Nardi G; Lhiaubet-Vallet V; Leandro-Garcia P; Miranda MA
Chem Res Toxicol; 2011 Oct; 24(10):1779-85. PubMed ID: 21923146
[TBL] [Abstract][Full Text] [Related]
11. Identification of photoproducts of florasulam in water using UPLC-QTOF-MS.
Qiao Y; Chen G; Ma C; Tao B; Ma H; Zhang X; Liu F
Environ Sci Pollut Res Int; 2019 Mar; 26(7):7132-7142. PubMed ID: 30649695
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection.
Hull CK; Martin PD; Warwick MJ; Thomas E
J Pharm Biomed Anal; 2004 May; 35(3):609-14. PubMed ID: 15137986
[TBL] [Abstract][Full Text] [Related]
13. Kinetic study on the photocatalytic degradation of salicylic acid using ZnO catalyst.
Rao AN; Sivasankar B; Sadasivam V
J Hazard Mater; 2009 Jul; 166(2-3):1357-61. PubMed ID: 19150585
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and bioconcentration of the pharmaceuticals moxifloxacin, rosuvastatin, and drospirenone to the unionid mussel Lampsilis siliquoidea.
Gilroy EA; Klinck JS; Campbell SD; McInnis R; Gillis PL; de Solla SR
Sci Total Environ; 2014 Jul; 487():537-44. PubMed ID: 24813769
[TBL] [Abstract][Full Text] [Related]
15. Photolysis of flumequine: identification of the major phototransformation products and toxicity measures.
Sirtori C; Zapata A; Gernjak W; Malato S; Agüera A
Chemosphere; 2012 Jul; 88(5):627-34. PubMed ID: 22513337
[TBL] [Abstract][Full Text] [Related]
16. [Rosuvastatin: pharmacologic features].
Bernini F; Catapano AL
Ital Heart J; 2003 Dec; 4 Suppl 7():22S-32S. PubMed ID: 14983744
[TBL] [Abstract][Full Text] [Related]
17. The issue of statin safety: where do we stand?
Grundy SM
Circulation; 2005 Jun; 111(23):3016-9. PubMed ID: 15911705
[No Abstract] [Full Text] [Related]
18. Rosuvastatin: characterization of induced myopathy in the rat.
Westwood FR; Scott RC; Marsden AM; Bigley A; Randall K
Toxicol Pathol; 2008 Feb; 36(2):345-52. PubMed ID: 18362199
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity evaluation of HMG CoA reductase inhibitor rosuvastatin.
Berber AA; Celik M; Aksoy H
Drug Chem Toxicol; 2014 Jul; 37(3):316-21. PubMed ID: 24245812
[TBL] [Abstract][Full Text] [Related]
20. An integrated chemical and ecotoxicological assessment for the photocatalytic degradation of vancomycin.
Lofrano G; Carotenuto M; Uyguner-Demirel CS; Vitagliano A; Siciliano A; Guida M
Environ Technol; 2014; 35(9-12):1234-42. PubMed ID: 24701920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
